Literature DB >> 17687422

Lead and neuroprotection by iron in ADHD.

Eric Konofal, Samuele Cortese.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17687422      PMCID: PMC1940080          DOI: 10.1289/ehp.10304

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


× No keyword cloud information.
We read with special interest the article by Braun et al. (2006). In this large survey, the authors concluded that prenatal exposure to tobacco and environmental lead are risk factors for attention deficit hyperactivity disorder (ADHD). We would like to focus on the potential neuroprotective role of iron against the deleterious effect of lead on the development of ADHD symptoms. Although the mechanisms underlying ADHD remain unclear, both genetic and environmental factors have been implicated. In a recent review on the implication of the dopaminergic system in the etiology of ADHD, Swanson et al. (2007) highlighted the importance of environmental risk factors as possible etiologies of dopamine deficit. Among these environmental factors, Swanson et al. (2007) cited the effects of lead exposure (at levels < 10 μg/dL) on ADHD-related behaviors and ADHD diagnosis. Lead in the central nervous system may contribute to dopaminergic dysfunction inducing alteration of dopamine release and dopamine receptor density (Gedeon et al. 2001; Lidsky et al. 2003). Moreover, lead may disrupt the structure of the blood–brain barrier function essential for brain integrity (Dyatlov et al. 1998). Interestingly, Wang et al. (2007) recently reported that iron supplementation protects the integrity of the blood–brain barrier against lead insults. On the other hand, iron deficiency could increase the toxic effect of lead, suggesting a potent neuroprotective effect of iron supplementation on dopaminergic dysfunction due to lead exposure (Wright 1999; Wright et al. 2003) In a controlled comparison group study, we (Konofal et al. 2004) showed that iron deficiency was correlated to ADHD symptoms severity, hypothesizing that iron supplementation may improve symptoms of ADHD in those subjects with low ferritin levels. Given that lead exposure may contribute to ADHD and iron deficiency may exacerbate deleterious effects caused by lead, we recommend systematically seeking for iron deficiency in children with ADHD. We also think that controlled studies assessing the potential effectiveness of iron supplementation on ADHD symptoms should be encouraged. Such studies could aid the understanding of the complex pathophysiology underlying ADHD and provide effective therapeutic strategies for this disorder.
  9 in total

1.  Association between iron deficiency and blood lead level in a longitudinal analysis of children followed in an urban primary care clinic.

Authors:  Robert O Wright; Shirng-Wern Tsaih; Joel Schwartz; Rosalind J Wright; Howard Hu
Journal:  J Pediatr       Date:  2003-01       Impact factor: 4.406

2.  Changes in mesocorticolimbic dopamine and D1/D2 receptor levels after low level lead exposure: a time course study.

Authors:  Y Gedeon; G T Ramesh; P J Wellman; A L Jadhav
Journal:  Toxicol Lett       Date:  2001-09-15       Impact factor: 4.372

3.  Lead potentiates cytokine- and glutamate-mediated increases in permeability of the blood-brain barrier.

Authors:  V A Dyatlov; A V Platoshin; D A Lawrence; D O Carpenter
Journal:  Neurotoxicology       Date:  1998-04       Impact factor: 4.294

Review 4.  Lead neurotoxicity in children: basic mechanisms and clinical correlates.

Authors:  Theodore I Lidsky; Jay S Schneider
Journal:  Brain       Date:  2003-01       Impact factor: 13.501

Review 5.  The role of iron therapy in childhood plumbism.

Authors:  R O Wright
Journal:  Curr Opin Pediatr       Date:  1999-06       Impact factor: 2.856

6.  Iron deficiency in children with attention-deficit/hyperactivity disorder.

Authors:  Eric Konofal; Michel Lecendreux; Isabelle Arnulf; Marie-Christine Mouren
Journal:  Arch Pediatr Adolesc Med       Date:  2004-12

Review 7.  Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis.

Authors:  James M Swanson; Marcel Kinsbourne; Joel Nigg; Bruce Lanphear; Gerry A Stefanatos; Nora Volkow; Eric Taylor; B J Casey; F Xavier Castellanos; Pathik D Wadhwa
Journal:  Neuropsychol Rev       Date:  2007-03       Impact factor: 7.444

8.  Iron supplement prevents lead-induced disruption of the blood-brain barrier during rat development.

Authors:  Qiang Wang; Wenjing Luo; Wei Zheng; Yiping Liu; Hui Xu; Gang Zheng; Zhongming Dai; Wenbin Zhang; Yaoming Chen; Jingyuan Chen
Journal:  Toxicol Appl Pharmacol       Date:  2006-12-08       Impact factor: 4.219

9.  Exposures to environmental toxicants and attention deficit hyperactivity disorder in U.S. children.

Authors:  Joe M Braun; Robert S Kahn; Tanya Froehlich; Peggy Auinger; Bruce P Lanphear
Journal:  Environ Health Perspect       Date:  2006-12       Impact factor: 9.031

  9 in total
  2 in total

1.  Effects of delta-aminolevulinic acid dehydratase polymorphisms on susceptibility to lead in Han subjects from southwestern China.

Authors:  Yuelin Yang; Jin Wu; Pin Sun
Journal:  Int J Environ Res Public Health       Date:  2012-07-02       Impact factor: 3.390

2.  Case-control study of blood lead levels and attention deficit hyperactivity disorder in Chinese children.

Authors:  Hui-Li Wang; Xiang-Tao Chen; Bin Yang; Fang-Li Ma; Shu Wang; Ming-Liang Tang; Ming-Gao Hao; Di-Yun Ruan
Journal:  Environ Health Perspect       Date:  2008-06-05       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.